BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 15629758)

  • 1. Ubiquitin-proteasome system and Parkinson's diseases.
    Betarbet R; Sherer TB; Greenamyre JT
    Exp Neurol; 2005 Feb; 191 Suppl 1():S17-27. PubMed ID: 15629758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological proteins in Parkinson's disease: focus on the proteasome.
    Snyder H; Wolozin B
    J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
    J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
    Corti O; Brice A
    Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
    Corti O; Brice A
    J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Lo Bianco C; Schneider BL; Bauer M; Sajadi A; Brice A; Iwatsubo T; Aebischer P
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17510-5. PubMed ID: 15576511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
    McNaught KS; Olanow CW
    Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cast of molecular characters in Parkinson's disease: felons, conspirators, and suspects.
    Lim KL; Dawson VL; Dawson TM
    Ann N Y Acad Sci; 2003 Jun; 991():80-92. PubMed ID: 12846976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathophysiology of Parkinson's disease.
    Moore DJ; West AB; Dawson VL; Dawson TM
    Annu Rev Neurosci; 2005; 28():57-87. PubMed ID: 16022590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
    J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
    Trimmer PA; Borland MK; Keeney PM; Bennett JP; Parker WD
    J Neurochem; 2004 Feb; 88(4):800-12. PubMed ID: 14756800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the genetic studies in Parkinson's disease].
    Krygowska-Wajs A; Wszolek Z
    Neurol Neurochir Pol; 2004; 38(2):127-36. PubMed ID: 15307606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into Parkinson's disease.
    Chung KK; Dawson VL; Dawson TM
    J Neurol; 2003 Oct; 250 Suppl 3():III15-24. PubMed ID: 14579120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New aspects of genetic contributions to Parkinson's disease.
    Hofer A; Gasser T
    J Mol Neurosci; 2004; 24(3):417-24. PubMed ID: 15655263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
    Chung KK; Zhang Y; Lim KL; Tanaka Y; Huang H; Gao J; Ross CA; Dawson VL; Dawson TM
    Nat Med; 2001 Oct; 7(10):1144-50. PubMed ID: 11590439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease.
    Hattori N; Shimura H; Kubo S; Wang M; Shimizu N; Tanaka K; Mizuno Y
    J Neural Transm Suppl; 2000; (60):101-16. PubMed ID: 11205133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of Parkinson's disease and biochemical studies of implicated gene products.
    Lansbury PT; Brice A
    Curr Opin Genet Dev; 2002 Jun; 12(3):299-306. PubMed ID: 12076673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.